08 July 2025
08 July 2025
The lawsuit states there is “a pressing public health emergency that demands immediate legal action and correction”.
The acquisition, announced in May 2025, saw GSK purchase Boston Pharmaceuticals' subsidiary BP Asset IX.
The treatment was developed in collaboration with Medicines for Malaria Venture.
The disease primarily affects middle-aged women and has a poor long-term prognosis despite therapeutic advances.
Ekterly’s efficacy was demonstrated through data from KalVista’s Phase III KONFIDENT clinical trial.
J&J is looking to add a hormone-sensitive indication to its prostate cancer therapy, which was originally approved in 2023.
The two organisations provide sustainable access to transformative treatments for children in need..
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
